Cargando…
Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
BACKGROUND: The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini-SSPedi)...
Autores principales: | Tomlinson, Deborah, Hyslop, Shannon, Stein, Eliana, Spiegler, Brenda, Vettese, Emily, Kuczynski, Susan, Schechter, Tal, Dupuis, L. Lee, Sung, Lillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325666/ https://www.ncbi.nlm.nih.gov/pubmed/30621617 http://dx.doi.org/10.1186/s12885-018-5210-z |
Ejemplares similares
-
Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments
por: Tomlinson, Deborah, et al.
Publicado: (2022) -
Refinement of the Symptom Screening in Pediatrics Tool (SSPedi)
por: O'Sullivan, C, et al.
Publicado: (2014) -
Longitudinal evaluation of Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a symptom screening and management application
por: Vettese, Emily, et al.
Publicado: (2019) -
Discordance between pediatric self‐report and parent proxy‐report symptom scores and creation of a dyad symptom screening tool (co‐SSPedi)
por: Tomlinson, Deborah, et al.
Publicado: (2020) -
Initial development of Supportive care Assessment, Prioritization and Recommendations for Kids (SPARK), a symptom screening and management application
por: Cook, Sadie, et al.
Publicado: (2019)